2018
| 02-14-2018: T2014-001 Reopens to Accrual at Dose Level #3 |
| 01-22-2018: Etopophos-Etoposide Memo |
2016
| 02-23-2016: Pfizer Adverse Event Notification |
| 02-23-2016: T2014-001 Reopens to Accrual at Dose Level #2 |
| 02-25-2016: T2014-001 Protocol Amendment #1 Distribution |
2015
| Protocol Investigator Meeting 3/17/2015: Slides |
| Protocol Activation Memo: 3/17/2015 |